Component
Unconjugated 6-gingerol in human plasma
Experimental species, exposure and limitations are retained on each claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
The sensitive 2011 assay did not detect free 6-gingerol in plasma after the 2 g ginger dose.
Experimental context and source evidence
- dose
- Ginger extract 2 g; LC-MS/MS lower quantification limit 2-5 ng/mL
- duration
- Sampling 0.25-24 h for parent analytes
- evidence_access
- Primary PubMed abstract.
- evidence_scope
- literature_reviewed; model-specific source-derived curation, not universally established human effects
- experimental_model
- Healthy human volunteers
- limitations
- Food/product and analytical sensitivity differ from the 2008 study. Non-detection is not proof of zero absorption.
- nutrient_topic
- Gingerols collection; each molecular form and experimental preparation remains explicit. · Gingerols
- organism
- Healthy human volunteers
- plain_language
- The sensitive 2011 assay did not detect free 6-gingerol in plasma after the 2 g ginger dose.
- primary_references
- Examination of the pharmacokinetics of active ingredients of ginger in humans. (2011). https://pubmed.ncbi.nlm.nih.gov/21638149/ DOI: 10.1208/s12248-011-9286-5
- route
- Oral mixed ginger extract
- tissue
- Plasma
Gingerols: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 382–391
Original AI-assisted curation of thirteen primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Healthy human volunteers · source_derived_draft · unverified_draft
## gingerols-6-human-free-null The sensitive 2011 assay did not detect free 6-gingerol in plasma after the 2 g ginger dose. Model/species: Healthy human volunteers Tissue: Plasma Exposure: Ginger extract 2 g; LC-MS/MS lower quantification limit 2-5 ng/mL Route: Oral mixed ginger extract Duration: Sampling 0.25-24 h for parent analytes Limits: Food/product and analytical sensitivity differ from the 2008 study. Non-detection is not proof of zero absorption. Primary reference: Examination of the pharmacokinetics of active ingredients of ginger in humans. (2011). https://pubmed.ncbi.nlm.nih.gov/21638149/ DOI: 10.1208/s12248-011-9286-5 Access: Primary PubMed abstract.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.